Research Frontiers Incorporated: Q3 2022 Form 10-Q Summary
Business Context and Reporting Period
Research Frontiers develops and licenses suspended particle device technology for electronically controlled light-management products, including automotive, architectural, aerospace, marine, appliance and other applications. The company operates in one business segment and primarily earns royalty and licensing fee income from licensees, with automotive representing the largest expected royalty market.
This unaudited report covers the three and nine months ended September 30, 2022, compared with the corresponding 2021 periods. The company had 33,150,396 common shares outstanding as of November 3, 2022.
Financial Performance and Position
| Metric | Three Months Ended September 30 | Nine Months Ended September 30 |
|---|---|---|
| Fee income | $150,443, versus $723,465 in 2021 | $409,783, versus $1,050,526 in 2021 |
| Operating expenses | $487,476, versus $571,024 | $1,770,414, versus $1,699,698 |
| Research and development | $149,156, versus $135,215 | $444,413, versus $420,203 |
| Operating income (loss) | $(486,189), versus $17,226 | $(1,805,044), versus $(1,069,375) |
| Net income (loss) | $(483,729), or $(0.02) per share | $(1,853,915), or $(0.06) per share |
| Net investment income (loss) | $2,460, versus $4,388 | $(48,871), versus $5,747 |
Fee income declined approximately 79% in the quarter and 61% year to date. The reported operating loss exceeded fee income in both periods, reflecting the company’s ongoing cost structure and limited revenue base. The filing does not present a separate gross margin measure.
At September 30, 2022, cash and cash equivalents were $4.8 million, compared with $270,000 at December 31, 2021. Working capital was approximately $5.2 million, total assets were $6.0 million, shareholders’ equity was $5.4 million, and accumulated deficit was $121.5 million. The company reported no debt; liabilities consisted primarily of operating lease obligations totaling approximately $511,000 in present value, with $586,000 of total liabilities.
Operating cash flow was $(1.616) million for the first nine months of 2022, compared with $(1.868) million in 2021. Investing activities provided $2.694 million, primarily from sales of marketable securities, while financing activities provided $3.450 million from the sale of common stock and warrants. The company held no marketable securities at September 30, 2022.
Material Changes Versus the Prior Comparable Period
- Third-quarter fee income fell by $573,022, while nine-month fee income fell by $640,743. Management attributed the decline primarily to the timing of payments and new or amended license agreements entered into during 2021.
- Management stated that, excluding those one-time timing effects, fee income would have been higher in 2022, mainly because of automotive and aircraft activity.
- Third-quarter operating expenses decreased $83,548, driven primarily by lower legal and professional fees and patent costs.
- Nine-month operating expenses increased $70,716, primarily due to a $152,000 increase in bad-debt expense and higher payroll, investor-relations, foreign-tax and insurance costs.
- Research and development expense increased $13,941 in the quarter and $24,210 year to date.
- The company sold marketable securities and recognized a $60,143 realized loss during the first nine months of 2022, converting the investments into cash and cash equivalents.
- In September 2022, the company agreed to sell 2.0 million shares at $2.30 per share, with one warrant per share exercisable at $2.76 through September 30, 2027. By September 30, it had received $3.450 million, issued 1.5 million shares and 1.5 million warrants, and expected to receive the remaining $1.150 million in November 2022.
Guidance, Outlook, Risks and Unusual Items
Management expects additional royalty income from new automotive and aircraft models and continued adoption in marine, train, museum and architectural applications. It also expects production efficiencies and lower technology pricing to expand market opportunities. These statements are forward-looking and are not guarantees.
The company projects a cash-flow shortfall of approximately $250,000 to $300,000 per quarter over the next 12 months and states that current working capital should support operations for more than five years, or at least through 2027 under current expectations. The company may reduce expenses or seek additional equity financing, but there is no assurance that financing will be available on acceptable terms.
Research Frontiers has incurred recurring losses since inception and has not generated sufficient license revenue to fund operations. Future viability depends substantially on commercialization by licensees and continuing royalty payments. Royalty income is concentrated among several licensees and is exposed to automotive production volumes, OEM model adoption, pricing, exchange rates, licensee financial condition and timing of royalty payments.
COVID-19-related manufacturing and supply-chain disruptions among overseas licensees continued to pose risks to product sales, royalty collections and receivable recoverability. The allowance for doubtful royalty receivables was $1.168 million at September 30, 2022, and the company recorded $151,772 of bad-debt expense during the first nine months.
Four licensees each represented at least 10% of nine-month fee income, accounting for approximately 29%, 25%, 11% and 10%, indicating material customer concentration. Four license agreements were in their initial multiyear terms; three expire December 31, 2022 and one expires December 31, 2024. Management expects annual renewals, but renewal is not assured. Remaining performance obligations under these agreements totaled approximately $100,000.
No income tax expense was recorded because the company has incurred operating losses and maintains a full valuation allowance against deferred tax benefits. Management reported effective disclosure controls and no material changes in internal control over financial reporting.
Important Facts for Investors to Verify
- Whether the expected November 2022 receipt of the remaining $1.150 million equity financing was completed and on what terms.
- Whether fee income rebounds as projected from automotive, aircraft and other new license applications, and whether revenue concentration changes.
- The collectability of royalty receivables and the adequacy of the $1.168 million allowance for doubtful accounts.
- Actual quarterly cash burn compared with the projected $250,000–$300,000 shortfall and the resulting operating runway.
- Renewal status and economics of the three license agreements scheduled to expire on December 31, 2022.
- Potential dilution from 2.900 million outstanding warrants and 1.069 million outstanding options as of September 30, 2022, in addition to the 1.5 million warrants issued in the September private placement.
- The effect of continued licensee manufacturing disruptions, automotive demand, OEM adoption and macroeconomic conditions on future royalties.